Growth Metrics

Evolent Health (EVH) Operating Leases (2019 - 2026)

Evolent Health has reported Operating Leases over the past 7 years, most recently at $19.2 million for Q4 2025.

  • For Q4 2025, Operating Leases fell 23.26% year-over-year to $19.2 million; the TTM value through Dec 2025 reached $19.2 million, down 23.26%, while the annual FY2025 figure was $19.2 million, 23.26% down from the prior year.
  • Operating Leases for Q4 2025 was $19.2 million at Evolent Health, up from $4.4 million in the prior quarter.
  • Over five years, Operating Leases peaked at $67.8 million in Q1 2021 and troughed at $4.4 million in Q3 2025.
  • A 5-year average of $45.7 million and a median of $54.3 million in 2022 define the central range for Operating Leases.
  • On a YoY basis, Operating Leases climbed as much as 12.41% in 2025 and fell as far as 87.53% in 2025.
  • Year by year, Operating Leases stood at $57.7 million in 2021, then decreased by 2.97% to $56.0 million in 2022, then plummeted by 32.14% to $38.0 million in 2023, then crashed by 34.31% to $25.0 million in 2024, then decreased by 23.26% to $19.2 million in 2025.
  • Business Quant data shows Operating Leases for EVH at $19.2 million in Q4 2025, $4.4 million in Q3 2025, and $8.4 million in Q2 2025.